All News

Proposition 61 would force state agencies to pay the same price for drugs paid by the US Department of Veterans Affairs.

The National Institutes of Health presented grants to 88 innovative biomedical researchers.

Adalimumab also found to be effective in treating non-infectious uveitis.

T cell subset may play a crucial role in the development of diabetes.

Niraparib significantly improved outcomes of platinum-sensitive recurrent ovarian cancer in landmark trial.

Top news of the day from across the healthcare landscape.

Atezolizumab is a PD-L1 inhibitor that uses the immune system to fight cancer.

Top news of the day from across the health care landscape.

A unique pattern of motion by repair proteins allows them to rapidly scan long DNA and flag repair machinery in condition that can lead to skin cancer.

Nintedanib extends progression-free survival in metastatic colorectal cancer, but failed to extend overall survival.

Oral Sunitinib reduced the likelihood of patients having kidney cancer return.

Coinfection with HIV plus a hepatitis B, C, or both, adds to the risk of non-Hodgkins lymphoma.

The FDA has approved Amjevita, also known as adalimumab-atto, as a biosimilar to Humira.

This article discusses Ozurdex dexamethasone implants as treatment for diabetic macular edema.

For some technicians, National Pharmacy Technician Day provides an opportunity to reflect upon what they mean to the pharmacy team.

The National Community Pharmacists Association (NCPA) today announced that PrescribeWellness, the cloud-based services company whose mission is to inspire collaboration for better health, has become the Official Medication Synchronization (Med Sync) Technology of NCPA's Simplify My Meds® program.

Halloween is a great time for pharmacists to educate the community about safety strategies.

Acceptance and utilization of biosimilar drugs still in need of improvement within specialty pharmacy.

Despite widespread criticism, the United States may be paying less for hepatitis c virus drugs than other developed countries.

Study finds that a food-poisoning bacteria increases the growth of gut bacteria linked to Crohn’s disease.

Patients with memory dysfunctions or depression may be less likely maintain adherence to oral oncoltyics.

Adjuvant therapy that improves outcomes for kidney cancer patients may finally be an option.

An award of $347 million has been given to 16 organizations involved with the Hospital Improvement and Innovation Network.

Indomethacin treats various rheumatic conditions, including many forms of tendinitis and arthritis.

Dupilumab shows benefits for the treatment of asthma and atopic dermatitis.

Ilaris is the first FDA-approved biologic treatment for Tumor Necrosis Factor–Receptor Associated Periodic Syndrome, Hyperimmunoglobulin D Syndrome/Mevalonate Kinase Deficiency and Familial Mediterranean Fever.

Ilaris is the first FDA-approved biologic treatment for Tumor Necrosis Factor–Receptor Associated Periodic Syndrome.

Cromolyn sodium associated with reduced liver fibrosis.

Anti-inflammatory cromolyn sodium shows potential to reduce liver fibrosis

Lucentis treats wet age-related macular degeneration and macular edema after retinal vein occlusion.